🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: Bladder cancer is the ninth most common type of cancer worldwid...
Status
Unknown
Location
policlinico Umberto I - Department of Gynecological-Obstetrics Sciences and Urological Sciences
Start Date
2017-01-01
Trial ID
NCT04228198
Treatments Being Tested
The purpose of this study is to determine if TAR-200, an investigational dr...
Status
Completed
Location
University of Southern California Norris Comprehensive Cancer Center
Start Date
2016-05-31
Trial ID
NCT02722538
Treatments Being Tested
Bladder cancer is a common malignant tumor of the urinary system, radical r...
Status
Recruiting
Location
Zhujiang Hospital
Start Date
2018-05-02
Trial ID
NCT03108196
The purpose of this study is to compare any good and bad effects of using U...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge (Consent and follow-up only)
Start Date
2016-08
Trial ID
NCT02908061
Treatments Being Tested
This is a single-arm, open-label, Phase Ib/II clinical trial designed to ev...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-04-30
Trial ID
NCT06957561
Comparison of effectiveness and safety of infection prevention silicone uri...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2018-08-03
Trial ID
NCT04152720
Treatments Being Tested
The purpose of the study to compare two established methods of radical cyst...
Status
Completed
Location
Department of Urology, Rigshospitalet
Start Date
2019-06-06
Trial ID
NCT03977831
Treatments Being Tested
This is a prospective multicentre randomised controlled trial comparing the...
Status
Completed
Location
North Bristol NHS Trust
Start Date
2017-03-01
Trial ID
NCT03049410
Treatments Being Tested
Erdafitinib (ERDA) alone or in combination with cetrelimab (CET) as neoadju...
Status
Recruiting
Location
CLCC Jean Perrin
Start Date
2023-03-07
Trial ID
NCT06511648
Treatments Being Tested
The purpose of this study is to evaluate the anti-tumor effects of TAR-200 ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2022-07-07
Trial ID
NCT04919512
Treatments Being Tested